14/02/2018 20:29:17

Vitalibis, Inc. Announces Name Change, Symbol Change and Forward Stock Split

LAS VEGAS, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Vitalibis Inc. (OTC:SALLD) (the "Company"), a technology-based seller of premium, full spectrum CBD oil, along with personal care and nutritional products formulated with premium hemp extracts, today announced that, effective February 8, 2018, the Company changed its name from Sheng Ying Entertainment Corp. to Vitalibis, Inc., accurately reflecting the Company's primary line of business within the full spectrum CBD oil, personal care and nutritional products markets. In addition to the name change, the Financial Industry Regulatory Authority (FINRA) has approved ”VCBD” as the Company's new ticker symbol. For a period of twenty business days, the Company will trade under the symbol 'SALLD,' after which, the Company will trade under the symbol 'VCBD.'

The name and symbol change follows Vitalibis, Inc, entering into a Plan of Merger with Sheng Ying Entertainment Corp., which became effective on February 8, 2018. In conjunction with the merge, Vitalibis, Inc., has also completed a 2.5 for 1 forward stock split of its common stock. The record date of the stock split was February 8, 2018. Shareholders of record as of such date have received 2.5 shares of the Company's common stock for each one share that they owned as of the market close on the record date. The distribution of the new shares was effected on February 8, 2018. The Company's transfer agent records have been updated to reflect the stock split and distribution of the new shares. As a result of the stock split, the issued and outstanding shares of the Company's common stock have increased from 10,804,000 shares to 27,010,000 shares.  The Company’s authorized shares of common stock have increased from 45,000,000 shares to 112,500,000 shares.

About Vitalibis, Inc.

Vitalibis endeavours to be an iconic lifestyle brand, which promotes health and wellness within the rapidly growing cannabis industry. Vitalibis seeks to utilize a robust technology platform and innovative micro-influencer sales model to market and sell premium, full spectrum CBD oil, along with personal care and nutritional products formulated with premium hemp extracts. In addition to leveraging technology and selling high-quality products, Vitalibis will focus on supporting non-profits with environmental and neuro-emotional missions.

For additional information, www.vitalibis.com

Contact:

Vitalibis Inc.

702-944-9620

Info@vitalibis.com

Forward-Looking Statements

This press release contains forward-looking statements, including statements such as "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include the future condition of the capital markets in general and the market for microcap securities. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Feb
NOVO-B
Når ens hustru har lidt voldsomt under diabetes  og dens bivirkninger tiltagende gennem 25 år, så er..
34
19 Feb
 
Jeg tager hatten for dit velbegrunede og fyldestgørende indlæg til debatten. Det kunne mange lære af..
32
21 Feb
GEN
Det er altid rart at møde et ungt menneske, der har potentiale til at blive klogere.
26
23 Feb
ZEAL
Jeg har tildigere her på EI rapporteret at Soliqua ville blive lanceret i Sydkorea. Nu har Sanofi af..
25
21 Feb
GEN
Du bliver da dummere og dummere at høre på 
21
17 Feb
NOVO-B
@alpenyt Tror bare jeg vil kalde dig for Wiki(pedia) fra nu af :) Du burde skrive en artikel i kvart..
17
23 Feb
ZEAL
Sanofi og  har for et par dage siden oplyst på clinicaltrial.gov at de starter studiet «LixiPark» me..
14
24 Feb
NRDF
  Aktieugen er overstået og desværre, men ikke særligt overraskende, viste det sig igen, at det dans..
12
23 Feb
GEN
H2 2018 er pakket med nyheder og kliniske data fra daratumumab i solide tumorer er en af de største ..
12
21 Feb
TRMD-A
Mange års erfaring i teknisk analyse berettiger mig til at give dig følgende svar:    Torm viser akt..
12

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Canada’s Johnston Grabs Lead after Day Two of FLW Tour at Harris Chain of Lakes Presented by Lowrance
2
OCEANTEAM ASA - REPORTS SOLID FY 2017 RESULTS UNDER DIFFICULT MARKET CONDITIONS AND FINANCIAL RESTRUCTURING
3
SUPER MICRO SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Super Micro Computer, Inc. - SMCI
4
METLIFE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against MetLife, Inc. - MET
5
Pomerantz Law Firm Announces the Filing of a Class Action against Bellicum Pharmaceuticals, Inc. and Certain Officers – BLCM

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 February 2018 00:10:19
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180222.1 - EUROWEB7 - 2018-02-25 01:10:19 - 2018-02-25 00:10:19 - 1000 - Website: OKAY